ID | 110922 |
Title Alternative | 尿毒素物質インドキシル硫酸はヘプシジン制御を介して慢性腎臓病における鉄代謝を障害する
Effect of indoxyl sulfate on hepcidin regulation
|
Author |
Hamano, Hirofumi
Tokushima University
Tokushima University Educator and Researcher Directory
KAKEN Search Researchers
Ikeda, Yasumasa
Tokushima University
Tokushima University Educator and Researcher Directory
KAKEN Search Researchers
Watanabe, Hiroaki
Tokushima University
Horinouchi, Yuya
Tokushima University
Izawa-Ishizawa, Yuki
Tokushima University
Tokushima University Educator and Researcher Directory
KAKEN Search Researchers
Takechi, Kenshi
Tokushima University
Ishizawa, Keisuke
Tokushima University
Tokushima University Educator and Researcher Directory
KAKEN Search Researchers
|
Keywords | Indoxyl sulfate
chronic kidney disease
CKD
hepcidin
iron
anemia
|
Content Type |
Thesis or Dissertation
|
Description | Background: Hepcidin secreted by hepatocytes is a key regulator of iron metabolism throughout the body. Hepcidin concentrations are increased in chronic kidney disease (CKD), contributing to abnormalities in iron metabolism. Levels of indoxyl sulfate (IS), a uremic toxin, are also elevated in CKD. However, the effect of IS accumulation on iron metabolism remains unclear.
Methods: We used HepG2 cells to determine the mechanism by which IS regulates hepcidin concentrations. We also used a mouse model of adenine-induced CKD. The CKD mice were divided into two groups: one was treated using AST-120 and the other received no treatment. We examined control mice, CKD mice, CKD mice treated using AST-120, and mice treated with IS via drinking water. Results: In the in vitro experiments using HepG2 cells, IS increased hepcidin expression in a dose-dependent manner. Silencing of the aryl hydrocarbon receptor (AhR) inhibited IS-induced hepcidin expression. Furthermore, IS induced oxidative stress, and antioxidant drugs diminished IS-induced hepcidin expression. Adenine-induced CKD mice demonstrated an increase in hepcidin concentrations; this increase was reduced by AST-120, an oral adsorbent of the uremic toxin. CKD mice showed renal anemia, decreased plasma iron concentration, increased plasma ferritin, and increased iron content in the spleen. Ferroportin was decreased in the duodenum and increased in the spleen. These changes were ameliorated by AST-120 treatment. Mice treated by direct IS administration showed hepatic hepcidin upregulation. Conclusion: IS affects iron metabolism in CKD by participating in hepcidin regulation via pathways that depend on AhR and oxidative stress. |
Journal Title |
Nephrology Dialysis Transplantation
|
ISSN | 09310509
14602385
|
NCID | AA1073277X
AA12096159
|
Publisher | Oxford University Press
|
Volume | 33
|
Issue | 4
|
Start Page | 586
|
End Page | 597
|
Published Date | 2017-08-23
|
Remark | 内容要旨・審査要旨・論文本文の公開
本論文は,著者Hirofumi Hamanoの学位論文として提出され,学位審査・授与の対象となっている。 This is a pre-copyedited, author-produced version of an article accepted for publication in Nephrology Dialysis Transplantation following peer review. The version of record, Nephrology Dialysis Transplantation (2017) Article ID: gfx252 is available online at: https://doi.org/10.1093/ndt/gfx252. |
EDB ID | |
DOI (Published Version) | |
URL ( Publisher's Version ) | |
FullText File | |
language |
eng
|
TextVersion |
ETD
|
MEXT report number | 甲第3101号
|
Diploma Number | 甲医第1345号
|
Granted Date | 2017-09-28
|
Degree Name |
Doctor of Medical Science
|
Grantor |
Tokushima University
|
departments |
Medical Sciences
University Hospital
Pharmaceutical Sciences
|